This subnnlsslon is in response to CAI 0-503 Comprehensive Partnerships to Reduce Cancer Health Disparities. This application, submitted by the Dana-Farber/Harvard Cancer Center and its partner UMASSBoston, describes plans to transition the successful U56 Partnership to a U54. From its inception, the Partnership has been based on strong institutional support, significant personal commitment of the leadership, and a belief in the institutional benefit that would be derived from a successful partnership. Two key tenets underlie the formation of our Partnership: a) a common and intense interest in addressing the problem of racial, ethnic, and socioeconomic disparities in cancer;and b) a belief that through the partnership, each partner will achieve benefits that neither could achieve on its own. Through careful planning, a mature, solid, and committed partnership has evolved which has been transformative for both institutions. This application provides extensive evidence of the ways these tenets have been operationalized and the resulting benefits, which have been substantial for both institutional partners. In addition to robust Administrative and Planning &Evaluation Cores, and two shared resources (Training Core and Statistical and Survey Methods Core), the application includes rigorous and innovative science, representing basic, clinical, and population science, as well as an innovative post-doctoral training program in nursing and health disparities. The Partnership has strong and enthusiastic personal and institutional support from the leaders of the respective institutions. The Partnership has well-established communication, leadership, and evaluation in place, and Is guided by an outstanding, external Program Steering Committee. This Partnership is fully prepared to move to the U54 mechanism.
This strong and stable Partnership has an excellent track record of developing cancer-focused research activities at the Minority Serving Institution, strengthening the cancer disparities and outreach research programs at the Comprehensive Cancer Center, and conducting robust student training programs. The Partnership is well-positioned to transition to a U54.
|Bellinger, Stephanie; Hatamimoslehabadi, Maryam; Borg, Raymond E et al. (2018) Characterization of a NIR absorbing thienyl curcumin contrast agent for photoacoustic imaging. Chem Commun (Camb) 54:6352-6355|
|Kumar, Niraj; Zarringhalam, Kourosh; Kulkarni, Rahul V (2018) Stochastic Modeling of Gene Regulation by Noncoding Small RNAs in the Strong Interaction Limit. Biophys J 114:2530-2539|
|Zarringhalam, Kourosh; Degras, David; Brockel, Christoph et al. (2018) Robust phenotype prediction from gene expression data using differential shrinkage of co-regulated genes. Sci Rep 8:1237|
|Patalano, Susan; Rodríguez-Nieves, José; Colaneri, Cory et al. (2018) CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled To Cullin-RING Ubiquitin Ligase Activation. Sci Rep 8:3499|
|Fakhry, Carl T; Zarringhalam, Kourosh; Kulkarni, Rahul V (2018) Bioinformatic Approach for Prediction of CsrA/RsmA-Regulating Small RNAs in Bacteria. Methods Mol Biol 1737:47-56|
|Borg, Raymond E; Rochford, Jonathan (2018) Molecular Photoacoustic Contrast Agents: Design Principles & Applications. Photochem Photobiol 94:1175-1209|
|Borg, Raymond E; Hatamimoslehabadi, Maryam; Bellinger, Stephanie et al. (2018) Photophysical and Photoacoustic Properties of ?-Extended Curcumin Dyes. Effects of the Terminal Dimethylamino Electron-donor and the Bridging Aryl Ring. Photochem Photobiol :|
|Webster, Kaitlyn A; Schach, Ursula; Ordaz, Angel et al. (2017) Dmrt1 is necessary for male sexual development in zebrafish. Dev Biol 422:33-46|
|Kang, Tianyu; Ding, Wei; Zhang, Luoyan et al. (2017) A biological network-based regularized artificial neural network model for robust phenotype prediction from gene expression data. BMC Bioinformatics 18:565|
|Horowitz, Jordan M; Kulkarni, Rahul V (2017) Stochastic gene expression conditioned on large deviations. Phys Biol 14:03LT01|
Showing the most recent 10 out of 33 publications